UnitedHealth Group (NYSE:UNH) Price Target Raised to $640.00

UnitedHealth Group (NYSE:UNH) had its price objective boosted by Oppenheimer from $610.00 to $640.00 in a research report report published on Friday,Benzinga reports. They currently have an outperform rating on the healthcare conglomerate’s stock.

Other analysts also recently issued research reports about the company. KeyCorp began coverage on UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price target on the stock. Truist Financial reissued a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Bank of America lowered their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $626.84.

UnitedHealth Group Stock Down 5.1 %

NYSE UNH opened at $549.62 on Friday. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $505.80 billion, a P/E ratio of 35.81, a price-to-earnings-growth ratio of 1.61 and a beta of 0.58. The stock’s 50-day moving average price is $586.84 and its 200-day moving average price is $559.07.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue was up 9.2% on a year-over-year basis. During the same period last year, the company posted $6.56 EPS. On average, equities research analysts predict that UnitedHealth Group will post 27.63 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.53%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the 3rd quarter valued at $27,000. Global Wealth Strategies & Associates raised its stake in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. Macroview Investment Management LLC lifted its position in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the third quarter worth about $32,000. Finally, Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth $31,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.